These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24958567)

  • 1. The line of 'no difference' is not engraved in stone: the utility of non-inferiority clinical trials.
    Joshi M; Ananth CV
    BJOG; 2014 Jul; 121(8):920-2. PubMed ID: 24958567
    [No Abstract]   [Full Text] [Related]  

  • 2. How They Did It: Increasing Transparency for Randomized Trial Methods.
    Brubaker L
    Female Pelvic Med Reconstr Surg; 2016; 22(4):181. PubMed ID: 27337409
    [No Abstract]   [Full Text] [Related]  

  • 3. [How (in-)complete are study reports?].
    Rakowitz B
    Dtsch Med Wochenschr; 2011 Apr; 136(15):752. PubMed ID: 21488003
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-inferiority study design: lessons to be learned from cardiovascular trials.
    Head SJ; Kaul S; Bogers AJ; Kappetein AP
    Eur Heart J; 2012 Jun; 33(11):1318-24. PubMed ID: 22564354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.
    Soonawala D; Middelburg RA; Egger M; Vandenbroucke JP; Dekkers OM
    Int J Epidemiol; 2010 Dec; 39(6):1567-81. PubMed ID: 20837637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundamentals of randomized clinical trials in wound care: reporting standards.
    Brölmann FE; Eskes AM; Sumpio BE; Mayer DO; Moore Z; Agren MS; Hermans M; Cutting K; Legemate DA; Vermeulen H; Ubbink DT
    Wound Repair Regen; 2013; 21(5):641-7. PubMed ID: 23937172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
    Schulz KF; Altman DG; Moher D;
    Int J Surg; 2011; 9(8):672-7. PubMed ID: 22019563
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary: The debate on non-inferiority trials: 'when meta-analysis alone is not helpful'.
    Liberati A; D'Amico R
    Int J Epidemiol; 2010 Dec; 39(6):1582-3. PubMed ID: 21113051
    [No Abstract]   [Full Text] [Related]  

  • 9. Discussion of paper by Korn and Freidlin.
    Wittes J
    Am J Bioeth; 2011 Mar; 11(3):13-4. PubMed ID: 21400376
    [No Abstract]   [Full Text] [Related]  

  • 10. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harms of outcome switching in reports of randomised trials: CONSORT perspective.
    Altman DG; Moher D; Schulz KF
    BMJ; 2017 Feb; 356():j396. PubMed ID: 28196813
    [No Abstract]   [Full Text] [Related]  

  • 12. Limitations of randomized clinical trials in chronic diseases: explanations and recommendations.
    Pincus T
    Adv Mind Body Med; 2002; 18(2):14-21. PubMed ID: 12629874
    [No Abstract]   [Full Text] [Related]  

  • 13. Statement on matching language to the type of evidence used in describing outcomes data.
    Editors of the HEART Group Journals
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):5. PubMed ID: 23244250
    [No Abstract]   [Full Text] [Related]  

  • 14. Korn and Freidlin's misunderstanding of the null hypothesis significance testing procedure.
    Trafimow D; Rice S
    Am J Bioeth; 2011 Mar; 11(3):15-6. PubMed ID: 21400377
    [No Abstract]   [Full Text] [Related]  

  • 15. Eroding precision in scientific communications: contagion from "the real world".
    Lyles A
    Clin Ther; 2007 Jan; 29(1):182. PubMed ID: 17379059
    [No Abstract]   [Full Text] [Related]  

  • 16. Reporting in randomized trials published in International Journal of Cardiology in 2011 compared to the recommendations made in CONSORT 2010.
    Chen HL; Liu K
    Int J Cardiol; 2012 Oct; 160(3):208-10. PubMed ID: 22738783
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
    Jansen JP; Fleurence R; Devine B; Itzler R; Barrett A; Hawkins N; Lee K; Boersma C; Annemans L; Cappelleri JC
    Value Health; 2011 Jun; 14(4):417-28. PubMed ID: 21669366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-inferiority trials: the 'at least as good as' criterion with dichotomous data.
    Laster LL; Johnson MF; Kotler ML
    Stat Med; 2006 Apr; 25(7):1115-30. PubMed ID: 16381070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting through the statistical fog: understanding and evaluating non-inferiority trials.
    Weintraub WS
    Int J Clin Pract; 2010 Sep; 64(10):1359-66. PubMed ID: 20716144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.